McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Carrum Health, GRAIL strike up partnership to offer cancer test to employers

by McKesson Ventures | Oct 19, 2022 | Portfolio News

Cancer has managed to be the most expensive condition increasing employers’ costs. Seeing this issue as an opportunity to collaborate Carrum Health and GRAIL have teamed up to create a solution. Carrum Health is a value-based platform that helps employers and...

NHS launches World’s Largest Trial of Cancer Blood Test

by McKesson Ventures | Sep 23, 2021 | Press Releases

The National Health Service (NHS) in the United Kingdom has announced the world’s largest trial of GRAIL’s Galleri blood test, which was developed to detect more than 50 types of cancer before symptoms appear. The NHS hopes to recruit 140,000 volunteers across the UK...

New multi-cancer early detection blood test study opens

by McKesson Ventures | Sep 17, 2021 | Portfolio News

The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more...

Drive to end cancer could pioneer diagnostic technology

by McKesson Ventures | Jun 15, 2021 | Portfolio News

GRAIL, the developer of multi-cancer early detection test Galleri, is building on its earlier commercial partnership with the UK’s National Health Service. That partnership aims to confirm Galleri’s clinical and economic performance in the UK healthcare system, which...

GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

by McKesson Ventures | Mar 16, 2021 | Press Releases

GRAIL has announced that it is joining forces with AccessHope™ to offer a world-class service experience to people who use Galleri™, GRAIL’s first-of-kind multi-cancer early detection blood test. This collaboration is part of GRAIL’s effort to help patients and their...
Page 1 of 1012345...10...»Last »

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth

Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow